A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA

The Journal of Emergency Medicine
Michael D SchwartzRoy R Gerona

Abstract

Since 2009, synthetic cannabinoid (SC) use has emerged as a growing public health threat in the United States (US). Several outbreaks of unexpected, severe toxicity linked to SC use have been reported since 2012. Reports of varied and significant morbidity after SC use are expected to increase because newer compounds enter the marketplace more frequently as manufacturers attempt to circumvent regulatory efforts. We report a cluster of 7 patients who experienced a spectrum of anxiety, delirium, psychosis, and aggressive behaviors after smoking the same SC-containing product at a party. An 8th patient with the same exposure source presented with delayed onset seizures. Biologic samples were analyzed for novel, newly identified SCs belonging to the FUBINACA family of compounds. A previously unknown SC, N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA) was identified in biologic samples from 7 of the individuals. ADB-PINACA was identified in the SC-containing product ("Crazy Clown") seized by law enforcement and identified as the product smoked by the 8 patients in the reported cluster. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: The information compiled using this cluster of cases, a...Continue Reading

References

Sep 15, 2010·Analytical and Bioanalytical Chemistry·Annette WintermeyerKatja Bender
Jul 12, 2011·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Joshua SimmonsCarl Skinner
Aug 2, 2011·The American Journal of Emergency Medicine·Amy C YoungKurt Kleinschmidt
Oct 6, 2011·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·J LapointJ H Moran
Dec 14, 2011·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Aaron B Schneir, Todd Baumbacher
May 9, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Kathryn A SeelyLiana Fattore
May 12, 2012·Annals of Emergency Medicine·Christopher O HoyteKennon J Heard
May 26, 2012·The American Journal of the Medical Sciences·Sadip PantGerson A Teran
Jul 25, 2012·Journal of Addiction Medicine·Babak Tofighi, Joshua D Lee
Aug 4, 2012·Human & Experimental Toxicology·M B ForresterA Young
Sep 20, 2012·The Journal of Emergency Medicine·Carson R Harris, Ashley Brown
Dec 18, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Gautam Kantilal BhanushaliDenyse Thornley-Brown
Jul 5, 2013·Journal of Forensic Sciences·Amy L PattonJeffery H Moran
Jan 24, 2014·The New England Journal of Medicine·Andrew A MonteEric J Lavonas

❮ Previous
Next ❯

Citations

Feb 16, 2016·Psychopharmacology·Michael B Gatch, Michael J Forster
Oct 21, 2015·Drug and Alcohol Dependence·Jolanta B Zawilska, Dariusz Andrzejczak
Oct 31, 2015·The Journal of Emergency Medicine·Jonathan Von Der HaarGetaw Worku Hassen
Jan 13, 2016·Journal of Analytical Toxicology·Kevin G ShanksGeorge Behonick
Aug 26, 2015·Annals of Emergency Medicine·Stephen L ThorntonRoy Gerona
Jul 15, 2015·The New England Journal of Medicine·Jordan TreckiMichael D Schwartz
Oct 8, 2016·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Juliana TournebizeJean-Pierre Kahn
Aug 16, 2016·Prehospital and Disaster Medicine·Thomas R ScaggsWilliam B Weir
Sep 18, 2016·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Matilda BäckbergAnders Helander
Apr 20, 2017·The New England Journal of Medicine·Ion Anghelescu
Dec 16, 2016·The New England Journal of Medicine·Axel J AdamsRoy Gerona
Apr 2, 2016·The American Journal of Hospice & Palliative Care·Rei TanakaIwao Osaka
Oct 16, 2018·Journal of Psychoactive Drugs·Jane Carlisle Maxwell
Jan 15, 2017·The Journal of Pharmacology and Experimental Therapeutics·Brian F ThomasJenny L Wiley
Oct 21, 2016·Nursing·Jeffrey PhillipsRichard Hsu
May 20, 2020·Clinical Practice and Cases in Emergency Medicine·Muhammed ErshadRichard Hamilton
Feb 25, 2017·Nursing Management·Jeffrey PhillipsRichard Hsu
Apr 8, 2017·International Scholarly Research Notices·Kenneth NugentDolores Buscemi
May 2, 2017·Journal of Analytical Toxicology·Barry K LoganMarilyn A Huestis
Apr 7, 2020·Archives of Toxicology·Dino Luethi, Matthias E Liechti
Jul 4, 2020·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Piotr Adamowicz
May 12, 2020·Frontiers in Pharmacology·Aliesha GriffinScott C Baraban
Aug 24, 2017·Drug Testing and Analysis·Richard C KevinBrian F Thomas
Apr 21, 2017·The New England Journal of Medicine·Feng-Shuo YangYi-Chin Lin
Aug 27, 2018·Amino Acids·Azzurra StefanucciAdriano Mollica
Nov 16, 2018·Neurotoxicology·Michael B Gatch, Michael J Forster
Dec 19, 2021·International Journal of Legal Medicine·Franziska Gaunitz, Hilke Andresen-Streichert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The New England Journal of Medicine
Andrew A MonteEric J Lavonas
MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention (CDC)
The Journal of Emergency Medicine
E M Koscove
The American Journal on Addictions
Stephanie PeglowGregory Briscoe
© 2022 Meta ULC. All rights reserved